Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer: Secondary Analysis of the GeparSixto Randomized Clinical Trial - Hahnen, E; Lederer, B; Hauke, J (JAMA Oncol, 2017)
et al.